Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:19:36 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



Q:PVCT - PROVECTUS BIOPHARMACEUTICALS INC - http://www.pvct.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PVCT - Qnot subscribed0.1985+0.00211.139.77200.1964  0.1985  0.19010.2245  0.05615:50:43Apr 1815 min RT 2¢

Recent Trades - Last 10 of 20
Time ETExPriceChangeVolume
15:50:43Q0.19850.00215,000
15:50:42Q0.196-0.00042,551
15:48:09Q0.19514-0.001265,000
15:23:56Q0.19015-0.00625900
15:23:56Q0.19015-0.00625100
14:29:49Q0.19850.00214,500
13:43:33Q0.19598-0.00042525
12:48:07Q0.1903-0.0061100
12:16:34Q0.19366-0.002742,500
12:15:39Q0.19366-0.002742,500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
2024-04-16 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
2024-04-11 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
2024-03-27 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
2024-03-12 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
2024-03-07 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
2024-02-29 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
2024-02-15 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
2024-02-14 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Engages irlabs for Investor Relations Services
2023-12-18 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
2023-11-15 09:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma
2023-11-13 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
2023-11-06 08:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
2023-08-07 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
2023-08-01 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
2023-06-28 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
2023-06-26 07:00U:PVCTNews ReleaseProvectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio